Active Iris in Retinopathy of Prematurity and Regression Following Intravitreal Ranibizumab Injection.
Classic active iris vasculature in retinopathy of prematurity is shown, as well as regression within 24 hours of off-label ranibizumab injection (0.25 mg) in both eyes. [Ophthalmic Surg Lasers Imaging Retina. 2018;49:643-644.].